CIK 0001425205 · Accelerated filer
IOVANCE BIOTHERAPEUTICS, INC.
Sign in to watch- Ticker
- IOVA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 753254381
- Phone
- 6502607120
- Business address
- 825 INDUSTRIAL ROAD, 4TH FLOOR, SAN CARLOS, CA, 94070
- Former names
- Lion Biotechnologies, Inc., Genesis Biopharma, Inc, FREIGHT MANAGEMENT CORP
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-12-02 | GRAF FINCKENSTEIN FRIEDRICH Chief Medical Officer | Option exercise · Restricted Stock Units | −3,906 | 19,533 | ||
| 2024-11-12 | Maynard Ryan D Director | Option exercise | +50,000 | $7.45 | $373K | 57,500 |
| 2024-11-12 | Maynard Ryan D Director | Sale | −50,000 | $10.06 | $503K | 7,500 |
| 2024-11-12 | Maynard Ryan D Director | Option exercise · Stock Option (right to buy) | −50,000 | 0 | ||
| 2024-10-14 | Vogt Frederick G Interim CEO & General Counsel | Option exercise | +20,834 | 213,096 | ||
| 2024-10-14 | Vogt Frederick G Interim CEO & General Counsel | Shares withheld for taxes | −8,851 | $9.77 | $86K | 204,245 |
| 2024-10-14 | Vogt Frederick G Interim CEO & General Counsel | Option exercise · Restricted Stock Units | −20,834 | 20,835 | ||
| 2024-10-14 | GRAF FINCKENSTEIN FRIEDRICH Chief Medical Officer | Option exercise | +2,813 | 62,155 | ||
| 2024-10-14 | GRAF FINCKENSTEIN FRIEDRICH Chief Medical Officer | Shares withheld for taxes | −1,428 | $9.77 | $14K | 60,727 |
| 2024-10-14 | GRAF FINCKENSTEIN FRIEDRICH Chief Medical Officer | Option exercise · Restricted Stock Units | −2,813 | 2,813 | ||
| 2024-10-14 | BILINSKY IGOR Chief Operating Officer | Option exercise | +2,813 | 57,235 | ||
| 2024-10-14 | BILINSKY IGOR Chief Operating Officer | Shares withheld for taxes | −1,428 | $9.77 | $14K | 55,807 |
| 2024-10-14 | BILINSKY IGOR Chief Operating Officer | Option exercise · Restricted Stock Units | −2,813 | 2,813 | ||
| 2024-09-03 | Vogt Frederick G Interim CEO & General Counsel | Option exercise | +10,417 | 169,726 | ||
| 2024-09-03 | Vogt Frederick G Interim CEO & General Counsel | Shares withheld for taxes | −4,426 | $10.85 | $48K | 165,300 |
| 2024-09-03 | Vogt Frederick G Interim CEO & General Counsel | Option exercise | +46,875 | 212,175 | ||
| 2024-09-03 | Vogt Frederick G Interim CEO & General Counsel | Shares withheld for taxes | −19,913 | $10.85 | $216K | 192,262 |
| 2024-09-03 | Vogt Frederick G Interim CEO & General Counsel | Option exercise · Restricted Stock Units | −10,417 | 62,504 | ||
| 2024-09-03 | Vogt Frederick G Interim CEO & General Counsel | Option exercise · Restricted Stock Units | −46,875 | 46,875 | ||
| 2024-09-03 | GRAF FINCKENSTEIN FRIEDRICH Chief Medical Officer | Option exercise | +3,907 | 49,778 |
Page 12 of 14 · 280 trades